Financial - Capital Markets
Compare Stocks
2 / 10Stock Comparison
MRX vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
MRX vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Capital Markets | Financial - Capital Markets |
| Market Cap | $3.60B | $307.53B |
| Revenue (TTM) | $3.63B | $103.14B |
| Net Income (TTM) | $526M | $16.18B |
| Gross Margin | 74.7% | 55.6% |
| Operating Margin | 32.0% | 17.1% |
| Forward P/E | 10.2x | 16.3x |
| Total Debt | $10.17B | $360.49B |
| Cash & Equiv. | $6.38B | $75.74B |
MRX vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 24 | May 26 | Return |
|---|---|---|---|
| Marex Group plc Ord… (MRX) | 100 | 260.0 | +160.0% |
| Morgan Stanley (MS) | 100 | 212.8 | +112.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MRX vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MRX is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 25.4%, EPS growth 42.3%
- Lower volatility, beta 0.74, current ratio 3.16x
- PEG 0.29 vs MS's 1.83
MS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 11 yrs, beta 1.37, yield 2.0%
- 7.4% 10Y total return vs MRX's 169.1%
- NIM 0.7% vs MRX's 0.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 25.4% NII/revenue growth vs MS's 16.8% | |
| Value | Lower P/E (10.2x vs 16.3x), PEG 0.29 vs 1.83 | |
| Quality / Margins | Efficiency ratio 0.4% vs MRX's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.74 vs MS's 1.37 | |
| Dividends | 2.0% yield, 11-year raise streak, vs MRX's 1.5% | |
| Momentum (1Y) | +66.7% vs MRX's +9.1% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs MRX's 0.4% |
MRX vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MRX vs MS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MRX leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
MS is the larger business by revenue, generating $103.1B annually — 28.4x MRX's $3.6B. Profitability is closely matched — net margins range from 13.0% (MS) to 8.5% (MRX).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.6B | $103.1B |
| EBITDAEarnings before interest/tax | $2.1B | $26.3B |
| Net IncomeAfter-tax profit | $526M | $16.2B |
| Free Cash FlowCash after capex | $883M | -$6.7B |
| Gross MarginGross profit ÷ Revenue | +74.7% | +55.6% |
| Operating MarginEBIT ÷ Revenue | +32.0% | +17.1% |
| Net MarginNet income ÷ Revenue | +8.5% | +13.0% |
| FCF MarginFCF ÷ Revenue | +18.0% | -2.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -33.8% | +48.9% |
Valuation Metrics
MRX leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 12.9x trailing earnings, MRX trades at a 47% valuation discount to MS's 24.3x P/E. Adjusting for growth (PEG ratio), MRX offers better value at 0.32x vs MS's 2.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.6B | $307.5B |
| Enterprise ValueMkt cap + debt − cash | $7.4B | $592.3B |
| Trailing P/EPrice ÷ TTM EPS | 12.94x | 24.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.23x | 16.28x |
| PEG RatioP/E ÷ EPS growth rate | 0.32x | 2.73x |
| EV / EBITDAEnterprise value multiple | 6.18x | 26.03x |
| Price / SalesMarket cap ÷ Revenue | 0.99x | 2.98x |
| Price / BookPrice ÷ Book value/share | 3.02x | 2.95x |
| Price / FCFMarket cap ÷ FCF | 5.50x | — |
Profitability & Efficiency
MRX leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
MRX delivers a 49.7% return on equity — every $100 of shareholder capital generates $50 in annual profit, vs $15 for MS. MS carries lower financial leverage with a 3.42x debt-to-equity ratio, signaling a more conservative balance sheet compared to MRX's 8.05x. On the Piotroski fundamental quality scale (0–9), MRX scores 6/9 vs MS's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +49.7% | +14.6% |
| ROA (TTM)Return on assets | +2.0% | +1.2% |
| ROICReturn on invested capital | +9.4% | +2.9% |
| ROCEReturn on capital employed | +7.9% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 8.05x | 3.42x |
| Net DebtTotal debt minus cash | $3.8B | $284.7B |
| Cash & Equiv.Liquid assets | $6.4B | $75.7B |
| Total DebtShort + long-term debt | $10.2B | $360.5B |
| Interest CoverageEBIT ÷ Interest expense | 1.54x | 0.44x |
Total Returns (Dividends Reinvested)
MRX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MRX five years ago would be worth $26,909 today (with dividends reinvested), compared to $24,217 for MS. Over the past 12 months, MS leads with a +66.7% total return vs MRX's +9.1%. The 3-year compound annual growth rate (CAGR) favors MRX at 39.1% vs MS's 34.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +32.4% | +7.4% |
| 1-Year ReturnPast 12 months | +9.1% | +66.7% |
| 3-Year ReturnCumulative with dividends | +169.1% | +142.1% |
| 5-Year ReturnCumulative with dividends | +169.1% | +142.2% |
| 10-Year ReturnCumulative with dividends | +169.1% | +739.4% |
| CAGR (3Y)Annualised 3-year return | +39.1% | +34.3% |
Risk & Volatility
Evenly matched — MRX and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
MRX is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.2% from its 52-week high vs MRX's 91.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | 1.37x |
| 52-Week HighHighest price in past year | $54.60 | $194.83 |
| 52-Week LowLowest price in past year | $27.91 | $117.21 |
| % of 52W HighCurrent price vs 52-week peak | +91.7% | +99.2% |
| RSI (14)Momentum oscillator 0–100 | 66.8 | 61.2 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 5.4M |
Analyst Outlook
MS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates MRX as "Buy" and MS as "Buy". Consensus price targets imply 9.8% upside for MRX (target: $55) vs 6.5% for MS (target: $206). For income investors, MS offers the higher dividend yield at 1.97% vs MRX's 1.46%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $55.00 | $205.75 |
| # AnalystsCovering analysts | 6 | 52 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +2.0% |
| Dividend StreakConsecutive years of raises | 0 | 11 |
| Dividend / ShareAnnual DPS | $0.73 | $3.81 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | +1.4% |
MRX leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). MS leads in 1 (Analyst Outlook). 1 tied.
MRX vs MS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is MRX or MS a better buy right now?
For growth investors, Marex Group plc Ordinary Shares (MRX) is the stronger pick with 25.
4% revenue growth year-over-year, versus 16. 8% for Morgan Stanley (MS). Marex Group plc Ordinary Shares (MRX) offers the better valuation at 12. 9x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate Marex Group plc Ordinary Shares (MRX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MRX or MS?
On trailing P/E, Marex Group plc Ordinary Shares (MRX) is the cheapest at 12.
9x versus Morgan Stanley at 24. 3x. On forward P/E, Marex Group plc Ordinary Shares is actually cheaper at 10. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Marex Group plc Ordinary Shares wins at 0. 29x versus Morgan Stanley's 1. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MRX or MS?
Over the past 5 years, Marex Group plc Ordinary Shares (MRX) delivered a total return of +169.
1%, compared to +142. 2% for Morgan Stanley (MS). Over 10 years, the gap is even starker: MS returned +739. 4% versus MRX's +169. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MRX or MS?
By beta (market sensitivity over 5 years), Marex Group plc Ordinary Shares (MRX) is the lower-risk stock at 0.
74β versus Morgan Stanley's 1. 37β — meaning MS is approximately 85% more volatile than MRX relative to the S&P 500. On balance sheet safety, Morgan Stanley (MS) carries a lower debt/equity ratio of 3% versus 8% for Marex Group plc Ordinary Shares — giving it more financial flexibility in a downturn.
05Which is growing faster — MRX or MS?
By revenue growth (latest reported year), Marex Group plc Ordinary Shares (MRX) is pulling ahead at 25.
4% versus 16. 8% for Morgan Stanley (MS). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53. 5% year-over-year, compared to 42. 3% for Marex Group plc Ordinary Shares. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MRX or MS?
Morgan Stanley (MS) is the more profitable company, earning 13.
0% net margin versus 8. 5% for Marex Group plc Ordinary Shares — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MRX leads at 32. 0% versus 17. 1% for MS. At the gross margin level — before operating expenses — MRX leads at 74. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MRX or MS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Marex Group plc Ordinary Shares (MRX) is the more undervalued stock at a PEG of 0. 29x versus Morgan Stanley's 1. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Marex Group plc Ordinary Shares (MRX) trades at 10. 2x forward P/E versus 16. 3x for Morgan Stanley — 6. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MRX: 9. 8% to $55. 00.
08Which pays a better dividend — MRX or MS?
All stocks in this comparison pay dividends.
Morgan Stanley (MS) offers the highest yield at 2. 0%, versus 1. 5% for Marex Group plc Ordinary Shares (MRX).
09Is MRX or MS better for a retirement portfolio?
For long-horizon retirement investors, Marex Group plc Ordinary Shares (MRX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
74), 1. 5% yield, +169. 1% 10Y return). Both have compounded well over 10 years (MRX: +169. 1%, MS: +739. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MRX and MS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.